
Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
The medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market."
The company's balance sheet gives it flexibility to execute a "meaningful number" of transactions without financial strain, Chief Financial Officer Thierry Piéton said at the J.P. Morgan healthcare conference on Monday.
"What's changing versus the last few years is coming back to doing more M&A," he said, adding that Medtronic's dividend policy remains unchanged.
Medtronic, which makes devices ranging from pacemakers to insulin pumps, reported a 3.7% rise in revenue to $33.6 billion in fiscal 2025.
The company is targeting deals in the low- to mid-single-digit billions of dollars, choosing targets that will supplement its internal R&D efforts, Martha said on Monday. The company has set up a new committee at the board level to move faster on deals, he added.
The executives said Medtronic is focused on two themes, expanding in areas where it already competes and acquiring enabling technologies for procedures such as cardiac ablation and surgical robotics.
The company has spent recent years improving operations by divesting non-core units and plans to spin off its diabetes business as MiniMed Group through a U.S. initial public offering following its struggles over the last few years.
It also added two new directors to its board last year after activist investor Elliott Investment Management emerged as one of its largest shareholders.
Medtronic now sees itself positioned to pursue strategic opportunities.
"We've earned the right to do these acquisition, and we've got the capacity, so we're going to step up," Piéton said.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona and Leroy Leo)
LATEST POSTS
- 1
The Green Transformation: 5 Feasible Living Practices - 2
US FDA unveils new pathway to approve personalized therapies - 3
Genome study reveals milestone in history of cat domestication - 4
Boeing's troubled capsule won't carry astronauts on next space station flight - 5
Wolf Bites Woman in Shocking Attack at Busy Shopping Center
The Leonid meteor shower is peaking early this week. Here’s what to know
A Manual for Nations with Extraordinary Food
French Senate debates social media ban for under-15s
This Canadian crater looks like marbled meat | Space photo of the day for Jan. 6, 2026
The Land Rover Freelander Is Back—But It’s No Longer a Land Rover
FDA approves Wegovy pill for weight loss
Man triggers smoke bomb during failed crypto robbery
Violence 'never part' of break-in plan, court told
This Luxurious Thermal Spa In Italy Is Perfect For A Relaxing Escape While Visiting Milan












